Mariangela Lecciso

872 total citations
15 papers, 359 citations indexed

About

Mariangela Lecciso is a scholar working on Immunology, Biological Psychiatry and Oncology. According to data from OpenAlex, Mariangela Lecciso has authored 15 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Biological Psychiatry and 4 papers in Oncology. Recurrent topics in Mariangela Lecciso's work include Immune Cell Function and Interaction (7 papers), Tryptophan and brain disorders (6 papers) and Immunotherapy and Immune Responses (3 papers). Mariangela Lecciso is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Tryptophan and brain disorders (6 papers) and Immunotherapy and Immune Responses (3 papers). Mariangela Lecciso collaborates with scholars based in Italy, Switzerland and United States. Mariangela Lecciso's co-authors include Antonio Curti, Darina Očadlíková, Valentina Salvestrini, Michèle Cavo, Sara Trabanelli, Marilena Ciciarello, Roberto M. Lemoli, Federica Loscocco, Giuseppe Visani and Alessandro Isidori and has published in prestigious journals such as Blood, The Journal of Immunology and Frontiers in Immunology.

In The Last Decade

Mariangela Lecciso

14 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariangela Lecciso Italy 9 170 101 97 75 56 15 359
Ilaria Durelli Italy 4 230 1.4× 116 1.1× 98 1.0× 57 0.8× 101 1.8× 5 433
Daniel Silberman United States 9 115 0.7× 87 0.9× 108 1.1× 9 0.1× 25 0.4× 13 334
Anna Gorelik Israel 7 99 0.6× 82 0.8× 164 1.7× 13 0.2× 16 0.3× 10 369
Sabrina Copsel United States 12 156 0.9× 137 1.4× 156 1.6× 94 1.3× 3 0.1× 27 421
Rikke Bæk Sørensen Denmark 10 256 1.5× 166 1.6× 142 1.5× 7 0.1× 89 1.6× 14 408
Saege Hancock United States 6 173 1.0× 44 0.4× 386 4.0× 10 0.1× 15 0.3× 15 602
Laura Barbieri Sweden 9 127 0.7× 111 1.1× 112 1.2× 10 0.1× 9 0.2× 13 332
Francesca Amoroso Italy 9 109 0.6× 58 0.6× 212 2.2× 16 0.2× 15 0.3× 13 586
Peggy Verdood Belgium 11 79 0.5× 75 0.7× 90 0.9× 13 0.2× 7 0.1× 18 357
Alexis L. Franks United States 8 75 0.4× 78 0.8× 154 1.6× 23 0.3× 12 0.2× 8 403

Countries citing papers authored by Mariangela Lecciso

Since Specialization
Citations

This map shows the geographic impact of Mariangela Lecciso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariangela Lecciso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariangela Lecciso more than expected).

Fields of papers citing papers by Mariangela Lecciso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariangela Lecciso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariangela Lecciso. The network helps show where Mariangela Lecciso may publish in the future.

Co-authorship network of co-authors of Mariangela Lecciso

This figure shows the co-authorship network connecting the top 25 collaborators of Mariangela Lecciso. A scholar is included among the top collaborators of Mariangela Lecciso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariangela Lecciso. Mariangela Lecciso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Očadlíková, Darina, Mariangela Lecciso, Javier Martín‐Broto, et al.. (2021). Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade. Frontiers in Immunology. 12. 577766–577766. 24 indexed citations
2.
Moresco, Monica, Mariangela Lecciso, Darina Očadlíková, et al.. (2019). Flow cytometry T cell profiling in a recent-onset narcoleptic type 1 child: a case report. Sleep Medicine. 68. 21–23. 2 indexed citations
3.
Očadlíková, Darina, Mariangela Lecciso, Alessandro Isidori, et al.. (2019). Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia. Frontiers in Oncology. 9. 1004–1004. 30 indexed citations
4.
Moresco, Monica, Mariangela Lecciso, Darina Očadlíková, et al.. (2018). Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease. Sleep Medicine. 44. 53–60. 15 indexed citations
5.
Parisi, Sarah, Darina Očadlíková, Mariangela Lecciso, et al.. (2018). Quantitative Assessment of Indoleamine 2,3-Dioxygenase (IDO) Expression at Diagnosis Predicts Clinical Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation. Blood. 132(Supplement 1). 5261–5261. 2 indexed citations
6.
Isidori, Alessandro, Federica Loscocco, Marilena Ciciarello, et al.. (2018). Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach. Cancers. 10(7). 211–211. 7 indexed citations
7.
Lecciso, Mariangela, Darina Očadlíková, Sabina Sangaletti, et al.. (2017). ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells. Frontiers in Immunology. 8. 1918–1918. 85 indexed citations
8.
Parisi, Sarah, Mariangela Lecciso, Darina Očadlíková, et al.. (2017). The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia. Frontiers in Immunology. 8. 1330–1330. 17 indexed citations
9.
Isidori, Alessandro, Federica Loscocco, Marilena Ciciarello, et al.. (2016). Renewing the immunological approach to AML treatment: from novel pathways to innovative therapies. 2(2). 226–251. 2 indexed citations
10.
Očadlíková, Darina, Sara Trabanelli, Valentina Salvestrini, et al.. (2015). CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1. Experimental Hematology. 43(4). 268–276.e5. 5 indexed citations
11.
Trabanelli, Sara, Mariangela Lecciso, Valentina Salvestrini, et al.. (2015). PGE2-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit anIn VitroAntileukemic Immune Response. Journal of Immunology Research. 2015. 1–10. 43 indexed citations
13.
Isidori, Alessandro, Valentina Salvestrini, Marilena Ciciarello, et al.. (2014). The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment. Expert Review of Hematology. 7(6). 807–818. 60 indexed citations
14.
Trabanelli, Sara, Darina Očadlíková, Marilena Ciciarello, et al.. (2014). The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells. The Journal of Immunology. 192(3). 1231–1240. 57 indexed citations
15.
Giorgi, Gianfranco, Mariangela Lecciso, Miriam Capri, et al.. (2014). An evaluation of genotoxicity in human neuronal-type cells subjected to oxidative stress under an extremely low frequency pulsed magnetic field. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 775-776. 31–37. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026